May 18, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Prescribing rates for leucovorin among youth with autism was 24-fold higher in November 2025 compared with the average prescribing rate from January 2023 to January 2025, according to a research letter published in JAMA Network Open. Joshua “Yoshi” Rothman, MD, MS, a clinical assistant professor of pediatrics at the University of California, San Diego School of Medicine, told
May 18, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Leucovorin Scripts Surged Even Before White House Autism Push

Trump and RFK Jr. Boosted This Unproven Autism Drug. Some Parents Listened

No clear autism link to antidepressant use during pregnancy, large study finds

Children’s Mental Health Visits Have Shot Up, Research Shows

Encoded's gene therapy reduced seizures in Dravet syndrome

Prescriptions rose sharply after widespread media attention early in 2025

The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients…

This week the FDA approved the generic drug as a treatment for autism – a move that shocked health experts

The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.

The FDA recently declined to endorse leucovorin for autism, citing a lack of strong evidence for it.

Trump administration officials are expected to discuss a medication called leucovorin as a potential treatment for autism.